PIPPR Project on CRISPR Base-Editors (ABE)


Great presentation by Roberto Nitsch, Safety Director, AstraZeneca at the NIST - Genome Editing Consortium Workshop 3rd May 2019 in US, on the idea behind their PIPPR project to understand the impact of CRISPR Base-Editors (ABE) on proteomic level.

PIPPR® is the first platform that offer the gene editing scientist an extensive and detailed protein expression analysis solution for any cells modified with CRISPR, ZFN or TALENs.

PIPPR® is powered by SWATH LC-MS, which gives you label-free proteome scale identification and quantification of any the protein in your cell.

Read more about PIPPR here.

Sign-Up COBO-Q Newsletter and receive the latest updates within Quality Control Genome Editing.


HashtagCRISPRHashtagCRISPR MedicineHashtagCRISPRQCHashtagGenome EditingHashtagPIPPRHashtagProteomic AnalysisHashtagQuality Control Genome EditingHashtagSafety